| mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0038 |
0.9 |
| mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.0046 |
0.9 |
| mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.0048 |
0.9 |
| mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0066 |
0.9 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
JQ12 |
GDSC1000 |
pan-cancer |
AAC |
0.0045 |
0.9 |
| mRNA |
AZD0530 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
CP466722 |
GDSC1000 |
pan-cancer |
AAC |
0.0037 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0045 |
0.9 |